Machatha Stephen 4
4 · Aldeyra Therapeutics, Inc. · Filed Apr 1, 2022
Insider Transaction Report
Form 4
Machatha Stephen
Chief Development Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-03-30+250,000→ 250,000 totalExercise: $4.52Exp: 2032-03-29→ Common Stock (250,000 underlying) - Award
Common Stock
2022-03-30+64,395→ 87,658 total
Holdings
- 211(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.
- [F2]Includes 2,972 shares previously purchased under the Issuer's Employee Stock Purchase Plan.
- [F3]These shares are held directly by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership over these shares for purposes of Section 16 or for any other purposes.
- [F4]The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2022.